225 related articles for article (PubMed ID: 9034327)
1. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
[TBL] [Abstract][Full Text] [Related]
2. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.
Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A
Oncogene; 1999 Oct; 18(44):5982-90. PubMed ID: 10557087
[TBL] [Abstract][Full Text] [Related]
4. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
5. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.
Berns A
J Cell Biochem; 1991 Oct; 47(2):130-5. PubMed ID: 1661736
[TBL] [Abstract][Full Text] [Related]
7. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
8. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
Mikkers H; Allen J; Berns A
Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of collaborating oncogenes in compound mutant mice.
Berns A; Mikkers H; Krimpenfort P; Allen J; Scheijen B; Jonkers J
Cancer Res; 1999 Apr; 59(7 Suppl):1773s-1777s. PubMed ID: 10197595
[TBL] [Abstract][Full Text] [Related]
10. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
Dolcetti R; Rizzo S; Viel A; Maestro R; De Re V; Feriotto G; Boiocchi M
Oncogene; 1989 Aug; 4(8):1009-14. PubMed ID: 2548143
[TBL] [Abstract][Full Text] [Related]
11. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.
Brightman BK; Chandy KG; Spencer RH; Gupta S; Pattengale PK; Fan H
J Immunol; 1988 Oct; 141(8):2844-54. PubMed ID: 2902139
[TBL] [Abstract][Full Text] [Related]
13. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
[TBL] [Abstract][Full Text] [Related]
14. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
[TBL] [Abstract][Full Text] [Related]
16. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
Alexander WS; Bernard O; Cory S; Adams JM
Oncogene; 1989 May; 4(5):575-81. PubMed ID: 2657573
[TBL] [Abstract][Full Text] [Related]
17. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
18. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
19. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
Dupressoir A; Heidmann T
Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer.
Saitoh T; Mine T; Katoh M
Int J Oncol; 2002 Apr; 20(4):785-9. PubMed ID: 11894125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
